用户名  找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: DNA Topoisomerases in Cancer Therapy; Present and Future Toshiwo Andoh Book 2003 Springer Science+Business Media New York 2003 DNA.biology.

[复制链接]
查看: 31291|回复: 44
发表于 2025-3-21 19:39:22 | 显示全部楼层 |阅读模式
书目名称DNA Topoisomerases in Cancer Therapy
副标题Present and Future
编辑Toshiwo Andoh
视频video
概述Commemorates the 30th anniversary of the discovery in 1971 of the first DNA topoisomerases, i.e topoisomerase I in E. coli.Pioneer Jim Wang at Harvard University, contributed an article: `Reflections
图书封面Titlebook: DNA Topoisomerases in Cancer Therapy; Present and Future Toshiwo Andoh Book 2003 Springer Science+Business Media New York 2003 DNA.biology.
描述.In the mid 80‘s type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology. .
出版日期Book 2003
关键词DNA; biology; cancer; cell; cell death; enzyme; enzymes; molecular biology; pharmacology; protein; resistance;
版次1
doihttps://doi.org/10.1007/978-1-4615-0141-1
isbn_softcover978-1-4613-4941-9
isbn_ebook978-1-4615-0141-1
copyrightSpringer Science+Business Media New York 2003
The information of publication is updating

书目名称DNA Topoisomerases in Cancer Therapy影响因子(影响力)




书目名称DNA Topoisomerases in Cancer Therapy影响因子(影响力)学科排名




书目名称DNA Topoisomerases in Cancer Therapy网络公开度




书目名称DNA Topoisomerases in Cancer Therapy网络公开度学科排名




书目名称DNA Topoisomerases in Cancer Therapy被引频次




书目名称DNA Topoisomerases in Cancer Therapy被引频次学科排名




书目名称DNA Topoisomerases in Cancer Therapy年度引用




书目名称DNA Topoisomerases in Cancer Therapy年度引用学科排名




书目名称DNA Topoisomerases in Cancer Therapy读者反馈




书目名称DNA Topoisomerases in Cancer Therapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:20:21 | 显示全部楼层
发表于 2025-3-22 04:13:41 | 显示全部楼层
发表于 2025-3-22 07:23:46 | 显示全部楼层
Degradation of topoisomerase cleavable complexes,Pl, hTOP2a and hTOP2β, have been demonstrated to be important molecular targets for anticancer drugs (Liu, 1989; Wang, 1985; Wang, 1996; Chen and Liu, 1994; Hsiang and Liu, 1988; Zhang ., 2001; Li and Liu, 2001; Mao .., 1999; Nitiss and Wang, 1996; Kingma and Oscheroff, 1998).
发表于 2025-3-22 08:50:37 | 显示全部楼层
Yeast as a model system in the analysis of DNA topoisomerase I poisons,anied by the formation of a covalent Top1-DNA intermediate, in which the active site tyrosine of Top1 is linked to a 3’ phosphoryl DNA end. This distinguishes type IB enzymes from other DNA topoisomerases, which form a 5’ phospho-tyrosyl linkage.
发表于 2025-3-22 16:12:25 | 显示全部楼层
Approaches to Artificial Intelligence,se II targeting agents act against the enzyme, what events following topoisomerase II inhibition are important for cytotoxicity, and how cells can elaborate resistance to topoisomerase II targeting agents.
发表于 2025-3-22 17:59:35 | 显示全部楼层
Understanding the action of drugs targeting TOP2: ,,se II targeting agents act against the enzyme, what events following topoisomerase II inhibition are important for cytotoxicity, and how cells can elaborate resistance to topoisomerase II targeting agents.
发表于 2025-3-22 22:43:00 | 显示全部楼层
at Harvard University, contributed an article: `Reflections .In the mid 80‘s type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investiga
发表于 2025-3-23 02:08:04 | 显示全部楼层
https://doi.org/10.1007/978-3-031-08743-1ing of the drug’s mechanism of action (5). The finding in 1985 that camptothecin specifically poisons top1 has generated great interest to find water-soluble, more efficacious and less toxic analogues of camptothecin.
发表于 2025-3-23 08:31:59 | 显示全部楼层
Gunay Kazimzade,Yasmin Patzer,Niels Pinkwartaction. The finding in 1985 that top1 was the target of camptothecin generated great interest to find water-soluble, more efficacious and less toxic analogues of camptothecin, and stimulated the search of non-camptothecin inhibitors (5, 6).
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-3 12:23
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表